Oleg Nodelman, Director at Kindred Biosciences, Inc. (KIN), bought 400,000 shares at $7.00 ($2.8M) on 2013-12-12, disclosed to the SEC on 2013-12-13.
Open-market purchase of $2.8M KIN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ZYME | BUY | 2025-03-13 | $26.2M | — | Filing → |
| NUVB | BUY | 2023-09-21 | $6.7M | — | Filing → |
| ANAB | BUY | 2021-05-04 | $5.1M | — | Filing → |